This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1293 |
6. Filter based on genotype QC (FinnGen only) |
1147 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Encephalitis
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1147 | 645 | 502 |
| Unadjusted period prevalence (%) | 0.23 | 0.23 | 0.23 |
| Median age at first event (years) | 49.94 | 46.74 | 54.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1195
- Matched controls
- 11950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
307.7
536
*
TAB00
NOMESCO Finland
Lumbar puncture
16.5
307.7
311
250
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.2
206.4
329
531
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.6
168.5
175
160
N03AX14
ATC
levetiracetam; systemic
12.9
147.6
150
132
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
140.4
132
*
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
135.0
127
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.1
133.4
196
282
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
125.3
118
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.4
124.7
175
238
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.6
118.9
148
173
AA1AD
NOMESCO Finland
CT of head and brain
3.8
111.7
550
2180
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
+∞
110.1
104
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.9
106.5
112
103
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.2
92.5
95
84
N03AX18
ATC
lacosamide; systemic
24.2
83.5
60
26
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
14.3
79.0
73
54
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.9
78.0
151
285
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
73.5
232
656
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
73.2
335
1217
G35
ICD-10 Finland
Multiple sclerosis
12.1
72.1
74
65
N03AF02
ATC
oxcarbazepine; oral
7.1
67.2
106
162
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
11.2
62.4
67
63
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.2
58.7
73
84
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
55.7
298
1168
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
17.9
55.2
45
26
R4120
NOMESCO Finland
Occupational therapy
4.2
54.2
156
408
R4150
NOMESCO Finland
Neuropsychological rehabilitation
14.1
53.9
50
37
A87.9
ICD-10 Finland
Viral meningitis, unspecified
+∞
53.5
51
*
G05.1*J09
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses
+∞
53.5
51
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.3
51.4
44
28
5AB01, ,
NOMESCO Finland
96.1
50.3
55
6
N05BA09
ATC
clobazam; oral
17.7
49.9
41
24
ZX120
NOMESCO Finland
Intravenous
3.6
49.7
184
573
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
15.3
48.7
43
29
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
48.3
46
*
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
45.1
43
*
N03AG01
ATC
valproic acid; systemic, rectal
4.0
44.2
136
372
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
43.0
41
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
42.3
164
524
R41.0
ICD-10 Finland
Disorientation, unspecified
6.0
41.7
76
134
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
40.9
39
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
410.8
40.3
40
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
40.1
639
4059
A28
ICPC
Limited function/disability NOS
2.6
39.4
272
1199
R50.9
ICD-10 Finland
Fever, unspecified
2.7
38.3
259
1128
N99
ICPC
Neurological disease other
9.3
37.9
46
51
32300
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa
+∞
36.6
35
*
G03.9
ICD-10 Finland
Meningitis, unspecified
68.8
35.2
40
6
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
34.8
324
1630
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
34.2
236
1034
183
Kela drug reimbursment
Lamotrigin and topiramate
10.0
34.0
39
40
F05.9
ICD-10 Finland
Delirium, unspecified
6.7
33.9
55
86
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
32.4
31
*
3238B
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]
+∞
31.4
30
*
R4130
NOMESCO Finland
Speech therapy
5.2
31.3
66
133
Z2445
NOMESCO Finland
Psychologist
4.0
31.2
92
243
109
Kela drug reimbursment
Multiple sclerosis
8.6
31.0
40
48
WX892
NOMESCO Finland
Monitored bed care
3.2
31.0
135
461
H02AB09
ATC
hydrocortisone; systemic
5.5
29.4
58
110
R4110
NOMESCO Finland
Physiotherapy
2.1
29.4
383
2185
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
106.0
28.8
31
*
L04AA06
ATC
mycophenolic acid; systemic
5.8
28.5
53
95
N03AX16
ATC
[U] pregabalin
2.2
28.5
313
1669
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.0
28.1
35
40
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
27.8
112
364
N03AB02
ATC
phenytoin; systemic
7.5
27.7
40
55
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
27.6
229
1085
R51.80
ICD-10 Finland
Headache
2.3
27.1
250
1238
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
27.0
127
452
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.7
27.0
51
93
N03AX12
ATC
[U] gabapentin; oral
2.3
26.9
233
1124
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.7
26.5
50
91
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
26.4
173
733
N71
ICPC
Meningitis/encephalitis
+∞
26.1
25
*
2AB04, ,
NOMESCO Finland
74.4
25.9
29
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
25.8
351
2018
L28
ICPC
Limited function/disability (L)
2.2
25.8
259
1326
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
25.8
160
660
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
25.1
24
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.6
25.0
32
38
R33
ICD-10 Finland
Retention of urine
2.9
23.9
119
437
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
7.9
23.9
33
43
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.4
23.7
61
145
6BA02, ,
NOMESCO Finland
42.4
23.7
29
7
G41.9
ICD-10 Finland
Status epilepticus, unspecified
24.2
23.6
33
14
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
8.1
23.1
31
39
G04.2
ICD-10 Finland
Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified
+∞
23.0
22
*
G05.1*J10.8
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus
+∞
23.0
22
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
8.3
22.7
30
37
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
22.7
107
381
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
22.5
144
602
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
22.3
188
891
L04AX01
ATC
azathioprine; systemic
3.4
21.9
80
244
Z3226
NOMESCO Finland
Physiotherapist
2.1
21.6
246
1314
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.5
21.5
42
79
M05BA04
ATC
alendronic acid; oral
2.7
21.0
120
474
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.4
20.8
53
125
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.8
20.7
26
30
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
20.5
111
426
H02AB06
ATC
prednisolone; systemic
1.8
20.4
579
4144
H02AB07
ATC
prednisone; oral
2.2
20.3
184
897
Z3231
NOMESCO Finland
Registered nurse
1.9
20.3
349
2148
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
48.9
20.2
24
5
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
20.0
142
622
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
19.9
94
335
N03AF01
ATC
carbamazepine; oral, rectal
3.2
19.6
82
272
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
19.5
187
933
XA400
NOMESCO Finland
EEG
17.5
18.8
29
17
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
18.6
95
353
R42
ICD-10 Finland
Dizziness and giddiness
1.9
18.5
291
1732
Z2221
NOMESCO Finland
Medical doctor
1.8
18.5
345
2168
N28
ICPC
Limited function/disability (N)
5.2
18.4
38
75
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
6.5
18.4
30
47
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.1
18.3
32
54
WX730
NOMESCO Finland
Conventional respirator
6.1
18.3
32
54
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
18.0
396
2609
WW400
NOMESCO Finland
Plasmaferesis
67.7
17.8
20
*
32308
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Alia definita
+∞
17.7
17
*
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
17.7
17
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
182.6
17.6
18
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.6
17.5
28
43
J05AB11
ATC
valaciclovir; oral
2.1
17.5
196
1035
N03AX09
ATC
lamotrigine; oral
2.9
17.4
82
292
M03BX01
ATC
baclofen; systemic
4.6
16.9
40
89
ZXD05
NOMESCO Finland
Urgent procedure
1.7
16.3
369
2438
RS221, ,
NOMESCO Finland
5.6
16.2
31
57
C03CA01
ATC
furosemide; systemic
1.8
16.1
333
2142
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
17.0
16.1
25
15
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
16.1
416
2849
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
15.7
15
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.9
15.6
28
24
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
162.0
15.5
16
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.8
15.4
28
49
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
15.4
89
353
N05BA01
ATC
diazepam; systemic, rectal
2.0
15.1
169
889
J01MA12
ATC
levofloxacin; systemic
1.9
15.1
221
1276
G41.0
ICD-10 Finland
Grand mal status epilepticus
45.6
15.1
18
*
G40
ICD-10 Finland
Epilepsy
6.0
14.8
26
44
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
14.8
34
74
N03AE01
ATC
clonazepam; systemic
2.7
14.7
79
302
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
4.1
14.6
40
100
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.4
14.6
24
38
JN4BD
NOMESCO Finland
Extensive body CT
2.2
14.4
127
609
N03AX23
ATC
brivaracetam; systemic
22.6
14.2
20
9
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.5
14.2
49
144
J05AB01
ATC
aciclovir; systemic
1.8
14.2
265
1647
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
43.0
14.1
17
*
G40.89
ICD-10 Finland
Other epilepsy
14.6
14.1
23
16
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
13.9
226
1346
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
54.0
13.8
16
*
A06AD11
ATC
lactulose; oral
2.0
13.8
175
962
J01AA02
ATC
doxycycline; systemic
1.7
13.7
883
7488
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
13.7
77
301
J01DB01
ATC
cefalexin; oral
1.8
13.7
975
8501
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
13.6
13
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.0
13.5
38
97
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
141.6
13.5
14
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.7
13.3
31
68
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
13.2
88
374
ZXD35
NOMESCO Finland
Usual procedure
3.2
13.2
52
167
R11
ICD-10 Finland
Nausea and vomiting
2.1
13.1
124
611
N05AH04
ATC
quetiapine; oral
1.8
12.8
230
1409
R53
ICD-10 Finland
Malaise and fatigue
1.7
12.7
318
2138
Z2446
NOMESCO Finland
Social worker
2.3
12.6
97
440
A02BC02
ATC
pantoprazole; systemic
1.6
12.5
776
6437
J01MA02
ATC
ciprofloxacin; systemic
1.6
12.5
435
3165
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.3
12.5
100
461
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.9
12.5
58
205
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
131.3
12.5
13
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.0
12.4
55
189
N03AX11
ATC
topiramate; oral
3.4
12.3
44
133
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
12.2
74
300
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
12.2
191
1122
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
21.5
12.0
17
8
ZXY02
NOMESCO Finland
Neuropsychologist
9.4
12.0
24
26
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
5.7
12.0
22
39
N06AX11
ATC
mirtazapine; oral
1.6
11.9
402
2898
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
11.7
164
929
H53.2
ICD-10 Finland
Diplopia
3.0
11.7
51
174
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.6
11.7
22
40
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
30.3
11.7
15
5
P01BA02
ATC
hydroxychloroquine; oral
2.2
11.6
99
469
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
11.5
11
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
11.3
237
1513
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
11.2
136
735
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
11.0
124
653
N29
ICPC
Neurological sympt/complt other
3.9
11.0
32
84
B02.0
ICD-10 Finland
Zoster encephalitis
43.7
10.9
13
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
10.9
43
138
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
10.9
128
683
N05CF01
ATC
zopiclone; oral
1.6
10.8
356
2540
PA6AD
NOMESCO Finland
CT of neck arteries
2.7
10.8
56
210
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
10.7
141
782
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.7
261
1731
SPAT1255
SPAT
Intravenous administration of medicine
2.3
10.7
83
377
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
10.5
50
179
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.3
10.5
21
23
J96.0
ICD-10 Finland
Acute respiratory failure
4.5
10.5
25
56
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.2
10.5
86
401
G05.1*J11.8
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis in suspected influenza
+∞
10.4
10
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.4
10
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.5
10.4
20
37
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.5
10.4
20
37
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
10.4
73
318
N88
ICPC
Epilepsy
8.3
10.3
22
27
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
10.2
285
1953
N18
ICPC
Paralysis/weakness
3.7
10.1
32
89
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
10.0
104
532
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
26.3
9.8
13
5
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
5.0
9.8
21
43
WX704
NOMESCO Finland
Intubation
2.1
9.7
99
502
N05BA04
ATC
oxazepam; oral
1.6
9.7
297
2077
N02AA05
ATC
oxycodone; systemic
1.7
9.6
194
1222
L04AA01
ATC
[U] ciclosporin
5.1
9.6
20
40
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.7
9.6
30
83
JN4AD
NOMESCO Finland
Body CT examination
1.9
9.5
130
730
B01AB05
ATC
enoxaparin; parenteral
1.5
9.5
330
2372
N05CD08
ATC
midazolam; nasal, systemic
3.3
9.5
36
113
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
9.4
313
2227
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
9.4
47
173
M31.1
ICD-10 Finland
Thrombotic microangiopathy
100.8
9.4
10
*
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
100.8
9.4
10
*
H46
ICD-10 Finland
Optic neuritis
4.9
9.3
20
41
SPAT1254
SPAT
Administration of medicine
1.7
9.3
171
1050
UKC02
NOMESCO Finland
Cystoscopy
1.7
9.2
166
1014
R1260
NOMESCO Finland
Evaluation of communicative skills
3.7
9.2
28
76
WX872
NOMESCO Finland
Intensive care
2.4
9.2
64
278
WX882
NOMESCO Finland
High dependency care
2.9
9.1
41
143
G61.0
ICD-10 Finland
Guillain-Barré syndrome
11.6
9.1
16
14
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.1
8.9
36
118
N06AA09
ATC
amitriptyline; systemic
2.0
8.9
102
541
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
8.8
103
549
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
8.8
24
60
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
8.8
102
542
SPAT1167
SPAT
Insertion of urinary catheter
3.0
8.8
39
135
N05AH03
ATC
olanzapine; systemic
2.1
8.8
83
410
N03AX25
ATC
cenobamate; oral
50.4
8.7
10
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.7
462
3610
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
8.7
113
625
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
8.7
71
331
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.8
8.6
19
40
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
8.6
75
359
R51
ICD-10 Finland
Headache
2.2
8.6
75
359
R5110, ,
SPAT
2.0
8.6
99
526
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.5
8.5
21
33
G41.2
ICD-10 Finland
Complex partial status epilepticus
27.7
8.5
11
*
1541, ,
Kela drug reimbursment
90.7
8.4
9
*
3069, ,
Kela drug reimbursment
90.7
8.4
9
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.3
8.4
21
49
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.4
595
4891
SPAT1216
SPAT
Assessment of functional ability
1.7
8.4
163
1015
H53.4
ICD-10 Finland
Visual field defects
3.3
8.4
31
96
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.9
8.4
18
23
A04
ICPC
Weakness/tiredness general
1.7
8.4
183
1176
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.7
8.4
19
41
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
8.4
55
233
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
8.3
81
404
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
8.3
151
923
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.1
8.3
22
54
N02BF02
ATC
pregabalin; oral
2.1
8.2
81
406
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
14.6
8.2
13
9
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
8.1
126
736
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
11.8
8.1
14
12
L04AX07
ATC
dimethyl fumarate; oral
9.0
8.0
16
18
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
22.2
8.0
11
5
H02AB04
ATC
methylprednisolone; systemic
1.7
8.0
160
1005
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
8.0
285
2052
N06AX21
ATC
duloxetine; oral
1.7
7.9
138
833
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
7.9
49
202
ZXA00
NOMESCO Finland
Right side
1.5
7.9
272
1944
A02BC01
ATC
omeprazole; systemic
1.5
7.8
287
2078
F05.8
ICD-10 Finland
Other delirium
7.0
7.8
18
26
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
45.3
7.7
9
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
7.7
32
107
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
7.6
231
1603
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
7.6
75
376
A69.2
ICD-10 Finland
Lyme disease
2.1
7.6
75
377
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
7.6
43
170
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.6
81
419
M35.1
ICD-10 Finland
Other overlap syndromes
10.1
7.5
14
14
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
7.5
119
699
XCK00
NOMESCO Finland
Perimetry
2.2
7.5
65
310
J01FF01
ATC
clindamycin; systemic
1.5
7.5
290
2120
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.5
384
2963
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.6
7.4
24
68
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
7.4
57
259
L01BA01
ATC
methotrexate; systemic
2.6
7.4
42
166
N02BE01
ATC
paracetamol; systemic, rectal
1.6
7.3
1017
9356
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
7.3
66
320
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
7.3
43
173
A89
ICD-10 Finland
Unspecified viral infection of central nervous system
+∞
7.3
7
*
G05.0*A17.8
ICD-10 Finland
Tuberculous meningoencephalitis
+∞
7.3
7
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
7.3
33
116
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.5
7.2
44
180
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
15.9
7.2
11
7
N05CD07
ATC
temazepam; oral
1.8
7.2
117
692
U07
ICPC
Urine symptom/complaint other
1.9
7.2
93
513
SPAT1234
SPAT
Support of social functional capacity
2.2
7.2
58
269
N86
ICPC
Multiple sclerosis
7.4
7.2
16
22
G40.10
ICD-10 Finland
Simple partial seizures
7.4
7.2
16
22
TKC22
NOMESCO Finland
Catheterisation instruction
3.1
7.2
29
95
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.2
71
357
XKD00
NOMESCO Finland
Uroflowmetry
1.7
7.1
145
915
G93.4
ICD-10 Finland
Encephalopathy, unspecified
12.1
7.1
12
10
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.1
89
487
T78.4
ICD-10 Finland
Allergy, unspecified
2.3
7.1
54
245
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
7.0
63
305
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
402
3156
ZXA05
NOMESCO Finland
Left side
1.5
7.0
243
1734
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
7.0
82
438
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.9
7.0
32
113
N05AX08
ATC
risperidone; systemic
1.8
6.9
99
564
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
6.9
28
92
N06AX16
ATC
venlafaxine; oral
1.6
6.9
163
1066
N03AX22
ATC
perampanel; oral
13.9
6.9
11
8
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
6.9
50
222
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
6.9
392
3073
WX002
NOMESCO Finland
Sedation and analgesia
1.5
6.9
198
1358
H47.1
ICD-10 Finland
Papilloedema, unspecified
6.7
6.8
16
24
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
6.8
121
735
G83.4
ICD-10 Finland
Cauda equina syndrome
11.0
6.8
12
11
N02BF01
ATC
gabapentin; oral
1.7
6.8
115
689
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
6.8
45
192
L03AB07
ATC
interferon beta-1a; parenteral
6.1
6.8
17
28
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.8
98
561
120
Kela drug reimbursment
Hypogammaglobulinaemia
40.3
6.8
8
*
R60.0
ICD-10 Finland
Localized oedema
1.7
6.8
131
815
OAB93, ,
SPAT
1.9
6.8
84
458
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.7
212
1482
R41.3
ICD-10 Finland
Other amnesia
2.7
6.7
35
133
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
6.7
58
278
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
6.7
46
200
S97
ICPC
Chronic ulcer skin
2.0
6.6
71
368
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.0
6.6
69
354
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.2
6.5
53
247
J01FA06
ATC
roxithromycin; oral
1.4
6.5
413
3289
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.5
185
1264
B02.8
ICD-10 Finland
Zoster with other complications
6.2
6.5
16
26
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
6.4
74
393
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
6.4
93
532
G81.1
ICD-10 Finland
Spastic hemiplegia
70.2
6.4
7
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
70.2
6.4
7
*
5CM18, ,
NOMESCO Finland
7.4
6.4
14
19
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
6.4
104
616
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.6
6.4
36
142
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
6.4
47
210
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.4
6.4
10
7
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
6.4
66
338
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.4
145
940
R06AE07
ATC
cetirizine; oral
1.4
6.3
475
3883
WW200
NOMESCO Finland
Immunization
2.6
6.3
34
131
XLA10, ,
NOMESCO Finland
2.3
6.3
47
211
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.3
103
611
M32
ICD-10 Finland
Systemic lupus erythematosus
18.1
6.3
9
5
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.3
809
7199
A85.8
ICD-10 Finland
Other specified viral encephalitis
+∞
6.3
6
*
B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.3
6
*
3238X
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]
+∞
6.3
6
*
G05.0
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere
+∞
6.3
6
*
GBB03
NOMESCO Finland
Percutaneous tracheostomy
+∞
6.3
6
*
WVA20
NOMESCO Finland
Medicine administration
2.5
6.2
37
150
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
26.8
6.2
8
*
ZXE00
NOMESCO Finland
One hour or less
1.4
6.2
407
3255
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.9
6.2
27
93
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.2
211
1499
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
6.1
76
414
N06BA07
ATC
modafinil; oral
7.7
6.1
13
17
G04BD11
ATC
fesoterodine; oral
2.9
6.1
28
99
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
6.1
137
885
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
3.8
6.1
18
48
C07AB07
ATC
bisoprolol; oral
1.4
6.0
479
3943
A46
ICD-10 Finland
Erysipelas
1.6
6.0
149
985
G43.3
ICD-10 Finland
Complicated migraine
3.0
6.0
26
89
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.7
6.0
31
117
B34.9
ICD-10 Finland
Viral infection, unspecified
2.4
6.0
39
165
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
261
95
34.87
307.65
1.2
1.1
—
—
—
0
0
204
40
61.29
307.65
1.3
1.1
—
—
—
0
0
440
236
28.93
307.65
1.6
1.2
3.62
3.70
mmol/l
0.45
425
223
283
93
39.56
307.65
1.4
1.8
—
—
—
0
0
187
40
55.24
307.65
1.5
2.3
—
—
—
0
0
284
59
62.83
307.65
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
243
55
55.20
307.65
1.3
1.1
—
—
—
0
0
376
231
23.29
307.65
1.7
1.4
84.12
32.17
e6/l
0.68
269
168
440
265
25.70
307.65
1.7
1.3
691.38
461.51
mg/l
10.28
434
253
378
235
23.06
307.65
1.8
1.5
660.46
657.08
e6/l
0.00
281
179
179
78
26.82
252.59
1.5
1.1
56.48
39.03
mg/l
1.99
163
60
173
74
27.17
245.70
1.3
1.1
335.77
233.46
mg/l
3.83
163
65
127
16
88.69
240.92
1.2
1.1
—
—
—
0
0
143
37
43.77
237.09
1.2
1.1
218.19
28.63
ng/l
—
70
8
167
74
26.07
233.80
1.3
1.1
—
—
—
0
0
142
39
41.19
231.77
1.2
1.1
—
—
—
0
0
126
26
54.06
219.73
1.3
1.1
—
—
—
0
0
124
26
53.10
215.46
1.3
1.1
—
—
—
0
0
121
24
55.98
212.62
1.2
1.0
—
—
—
0
0
122
26
52.14
211.20
1.3
1.0
—
—
—
0
0
146
66
25.06
202.29
1.4
1.2
0.61
0.52
ratio
2.15
90
38
370
718
7.02
194.35
2.8
2.5
25.72
18.14
au/ml
0.64
26
75
187
159
13.76
189.05
1.3
1.1
—
—
—
0
0
349
655
7.11
189.04
1.5
1.3
71.60
41.27
au/ml
1.19
20
48
109
26
46.03
183.65
1.3
1.1
—
—
—
0
0
129
66
21.79
169.37
1.4
1.0
1.16
1.06
u/l
0.53
56
34
74
13
60.61
132.28
1.5
1.0
—
—
—
0
0
197
305
7.54
125.33
1.2
1.1
1.38
4.03
—
5
44
120
104
12.71
118.74
1.5
1.8
—
—
—
0
0
86
39
23.68
118.10
1.1
1.0
—
—
—
0
0
69
15
48.76
118.08
1.4
1.3
—
—
—
0
0
327
869
4.80
116.08
3.7
2.7
9.87
10.71
g/l
2.81
307
805
54
11
51.37
93.42
1.4
1.2
—
—
—
0
0
53
14
39.57
86.29
1.2
1.0
—
—
—
0
0
52
14
38.79
84.22
1.2
1.0
—
—
—
0
0
50
15
34.75
78.57
1.2
1.0
—
—
—
0
0
47
13
37.59
75.48
1.6
2.4
—
—
—
0
0
75
63
12.63
75.22
3.2
2.2
231.18
182.69
e6/l
1.08
66
52
87
93
10.01
74.16
1.6
1.9
—
—
—
0
0
72
63
12.10
70.33
3.1
2.2
518.89
454.25
e6/l
0.35
62
48
403
1696
3.08
68.09
2.2
1.9
—
—
—
0
0
597
3123
2.82
67.07
3.2
2.2
218.00
239.27
u/l
0.16
582
2977
68
60
11.96
66.03
1.4
1.0
1586.94
1599.52
miu/ml
0.02
68
60
377
1563
3.06
64.97
2.6
2.3
28.81
29.37
s
1.53
372
1518
328
1271
3.18
63.39
2.1
1.8
—
—
—
0
0
122
235
5.67
61.31
3.0
3.7
28.33
34.09
umol/l
2.28
107
216
65
61
11.21
60.56
2.9
2.1
—
—
—
0
0
67
9
78.93
59.71
1.4
1.2
—
—
—
0
0
64
7
96.56
58.48
1.3
1.1
—
—
—
0
0
730
4443
2.65
57.59
6.3
5.3
34.80
35.99
g/l
5.75
697
4187
303
1215
3.00
54.25
2.2
1.9
—
—
—
0
0
141
346
4.49
53.17
1.3
1.3
—
—
—
0
0
714
4488
2.47
49.66
10.0
7.2
1.20
1.21
mmol/l
2.97
672
4156
60
67
9.38
49.31
1.2
1.2
—
—
—
0
0
131
335
4.27
46.67
5.1
1.6
0.21
0.23
g/l
2.54
125
323
52
7
77.73
46.34
1.3
1.1
—
—
—
0
0
857
5960
2.55
46.14
8.3
5.5
6.74
6.63
mmol/l
0.69
834
5633
765
5058
2.42
46.05
10.6
7.8
1.21
1.21
mmol/l
0.83
681
4392
480
2594
2.42
45.90
5.3
4.3
89.83
90.70
%
0.35
467
2540
132
349
4.13
44.93
5.2
1.6
1.10
1.20
g/l
3.26
126
335
156
480
3.59
42.66
1.9
2.1
34.00
39.14
u/l
2.22
143
432
502
2865
2.30
41.29
4.8
3.3
0.28
0.43
e6/l
1.73
387
2089
558
3331
2.27
41.14
4.8
3.4
40.10
74.14
e6/l
0.78
444
2527
191
692
3.09
39.98
2.5
1.7
1.18
1.39
g/l
0.82
176
643
47
9
54.26
39.78
1.3
1.1
—
—
—
0
0
843
6026
2.35
39.31
14.2
9.8
4.29
4.08
e9/l
1.56
735
5259
204
803
2.86
36.62
2.3
3.0
65.73
66.78
g/l
0.87
188
748
676
4523
2.14
35.61
15.1
13.7
1.21
1.23
inr
0.44
576
3763
142
461
3.36
35.51
5.8
1.9
15.97
6.92
iu/ml
1.65
45
106
96
238
4.30
35.45
1.5
1.5
—
—
—
0
0
168
609
3.05
34.92
1.9
1.7
—
—
—
0
0
890
6669
2.31
34.68
7.1
4.6
354.25
1327.15
e6/l
—
8
104
341
1770
2.30
33.93
4.3
3.0
1.09
1.01
e6/l
0.18
182
925
118
351
3.62
33.75
2.3
2.8
—
—
—
0
0
37
6
63.55
32.20
1.1
1.0
—
—
—
0
0
285
1397
2.37
32.20
7.9
6.5
1.04
1.05
mmol/l
0.26
266
1298
36
5
73.99
32.02
1.3
1.2
—
—
—
0
0
36
5
73.99
32.02
1.1
1.0
—
—
—
0
0
87
217
4.25
31.83
1.1
1.1
23.30
16.26
au/ml
—
5
63
70
149
4.93
31.18
1.6
2.0
—
2306.67
—
0
6
400
2280
2.13
31.09
3.5
2.7
4.39
6.14
e6/l
2.87
374
2085
327
1723
2.24
30.99
4.5
3.8
0.81
0.82
mmol/l
0.10
301
1642
118
373
3.40
30.68
1.7
1.5
0.20
0.09
iu/ml
0.39
24
62
81
197
4.34
30.62
1.4
1.3
—
—
—
0
0
81
197
4.34
30.62
1.4
1.3
—
—
—
0
0
243
1136
2.43
30.37
4.4
4.7
282.74
251.13
u/l
0.54
228
1075
313
1650
2.22
29.43
4.5
3.2
3.02
2.42
e6/l
0.33
149
803
227
1048
2.44
29.07
4.7
4.4
1.46
1.83
mmol/l
0.84
199
901
230
1089
2.38
27.74
4.7
4.3
5.71
5.81
kpa
0.78
225
1061
223
1055
2.37
26.88
2.6
2.1
347.94
378.68
nmol/l
1.64
207
989
103
333
3.29
25.76
1.9
2.7
10.51
10.32
g/l
0.11
88
306
67
161
4.35
25.70
5.5
6.0
339.39
366.86
umol/l
0.84
59
143
60
132
4.73
25.68
1.1
1.2
—
—
—
0
0
731
5394
1.91
25.36
7.5
6.7
10.33
11.83
umol/l
4.23
702
5164
96
300
3.39
25.34
1.9
2.3
11.74
11.63
mg/l
0.05
87
281
42
69
6.27
24.67
3.6
2.6
44.85
42.52
%
0.28
26
32
619
4375
1.86
24.07
2.5
2.1
92.78
95.64
pmol/l
0.84
356
2304
34
15
23.29
23.98
1.5
1.6
—
—
—
0
0
197
930
2.34
23.66
3.8
3.9
4.75
4.53
kpa
0.81
191
907
109
386
3.01
23.35
1.9
2.5
3.99
4.24
g/l
1.86
94
360
109
386
3.01
23.35
1.9
2.5
7.30
7.35
g/l
0.11
93
360
109
386
3.01
23.35
1.9
2.5
3.68
3.70
g/l
0.02
94
360
72
196
3.84
23.34
3.0
3.7
1951.60
2090.50
u/ml
—
5
14
953
7795
2.10
23.30
11.5
8.2
77.99
79.07
u/l
0.37
922
7439
202
973
2.29
23.12
10.3
8.9
1.47
1.33
mmol/l
1.07
195
955
330
1927
1.98
22.82
3.9
3.9
141.53
412.26
ng/l
2.95
250
1436
226
1147
2.20
22.76
11.2
9.4
1.08
0.92
mmol/l
0.21
186
954
31
12
26.47
22.72
1.2
1.1
—
—
—
0
0
101
349
3.07
22.57
2.0
1.8
—
—
—
0
0
227
1169
2.16
21.98
11.2
9.2
4.99
5.13
kpa
1.23
217
1131
190
910
2.29
21.97
7.8
8.6
8.44
9.34
mmol/l
1.03
181
876
227
1170
2.16
21.93
11.1
9.2
11.95
12.37
kpa
0.63
217
1134
103
366
2.99
21.91
1.9
2.6
2.89
2.94
g/l
0.17
88
340
87
280
3.27
21.89
1.6
1.7
—
—
—
0
0
81
250
3.40
21.78
5.1
6.9
266.13
337.31
iu/ml
—
8
32
72
209
3.60
21.26
1.3
1.5
—
—
—
0
0
283
1602
2.00
21.18
1.8
1.7
987.07
1178.98
nmol/l
3.60
224
1220
82
266
3.24
20.36
1.9
2.9
0.00
0.00
g/l
-0.00
72
252
87
296
3.09
19.95
1.8
2.8
0.04
0.02
g/l
0.23
74
268
636
4713
1.75
19.51
15.1
11.2
0.00
0.00
e9/l
0.61
500
3852
25
8
31.87
19.30
1.3
1.0
—
—
—
0
0
85
291
3.07
19.28
1.8
2.8
0.00
0.00
g/l
-0.00
72
253
63
179
3.66
19.21
1.5
1.3
3.21
6.43
u/ml
0.95
39
74
81
273
3.11
18.87
1.5
1.6
—
—
—
0
0
92
337
2.87
18.51
1.8
2.8
1.37
0.82
g/l
0.40
76
298
101
389
2.74
18.49
2.2
2.1
1.04
2.03
ug/l
0.66
94
346
909
7540
1.86
18.21
6.5
4.3
13.19
11.28
mm/h
3.56
869
7087
17
0
+∞
17.75
1.1
0.0
—
—
—
0
0
197
1039
2.07
17.66
12.1
9.8
95.59
95.60
%
0.01
192
1009
702
5455
1.70
17.17
5.9
3.8
0.00
0.00
estimate
0.50
144
1153
711
5555
1.69
16.94
5.9
3.9
0.00
0.29
estimate
0.53
136
1098
706
5511
1.69
16.82
5.9
3.8
7.32
4.18
estimate
0.17
147
1176
367
2404
1.76
16.81
2.0
1.8
1.04
1.19
mg/l
0.54
281
1829
357
2326
1.76
16.63
2.0
1.5
2.14
2.37
g/l
2.15
248
1473
22
9
24.86
16.03
1.1
1.0
2.13
—
u/l
—
7
0
404
2757
1.70
15.78
2.5
2.3
2.95
2.83
mg/l
0.36
348
2368
105
446
2.48
15.75
2.5
2.3
1.63
1.45
g/l
0.97
87
400
489
3517
1.66
15.60
3.7
3.4
2.34
2.36
mmol/l
1.65
446
3228
496
3590
1.65
15.37
4.5
3.4
40.38
31.98
u/l
0.56
470
3416
611
4674
1.63
15.07
2.9
2.5
75.32
76.07
nmol/l
0.25
564
4260
57
178
3.31
15.06
1.5
1.2
4.04
4.73
u/ml
0.12
25
60
19
6
32.14
14.83
1.1
1.0
—
—
—
0
0
848
7086
1.68
14.31
4.6
3.4
53.31
46.83
u/l
1.00
807
6723
514
3806
1.62
14.21
4.8
3.7
32.95
57.79
ng/l
0.82
370
2579
83
331
2.62
14.19
1.7
1.2
32.94
13.44
u/ml
—
7
13
30
61
5.02
14.10
1.0
1.0
380.44
275.67
ng/l
0.70
25
40
144
734
2.09
14.00
1.8
1.7
—
—
—
0
0
56
182
3.18
13.89
1.6
1.8
—
—
—
0
0
31
69
4.59
13.11
1.2
1.6
—
—
—
0
0
29
61
4.85
13.11
1.0
1.0
687.65
656.88
ng/l
0.12
23
41
29
61
4.85
13.11
1.0
1.0
38.05
36.08
ng/l
0.10
23
38
72
280
2.67
12.94
1.7
1.6
—
—
—
0
0
407
2899
1.61
12.90
1.8
1.7
17.58
20.24
nmol/l
4.87
373
2484
159
865
1.97
12.88
2.9
3.1
68.35
70.74
e9/l
0.31
107
639
444
3254
1.58
12.35
2.9
2.6
57.15
61.47
u/l
0.87
416
3050
62
229
2.80
12.31
1.3
1.5
154.58
154.28
au/ml
0.01
19
67
66
253
2.70
12.21
1.8
1.2
5.80
6.21
u/ml
—
5
17
68
267
2.64
12.00
1.2
1.4
316.68
232.51
u/ml
0.74
37
158
75
315
2.47
11.54
1.8
1.2
17.57
2.43
u/ml
0.89
12
28
42
130
3.31
11.30
1.3
1.5
279.70
279.25
mosm/kgh2o
0.03
33
92
142
781
1.93
11.10
4.1
4.4
80.50
85.52
ng/l
0.35
125
697
61
237
2.66
11.01
1.5
1.7
—
—
—
0
0
74
316
2.43
10.99
1.8
1.2
8.24
8.84
u/ml
0.04
19
46
54
197
2.82
10.99
1.6
1.5
—
—
—
0
0
66
270
2.53
10.74
3.0
3.9
3.21
2.35
ratio
0.25
48
153
1094
10062
2.03
10.73
28.7
15.5
24.03
23.58
mg/l
0.20
995
8272
57
219
2.68
10.52
1.8
1.5
—
—
—
0
0
168
999
1.79
10.24
2.4
2.4
37.19
37.28
u/l
0.00
151
834
137
767
1.89
10.13
1.6
1.3
111.99
233.58
u/ml
2.19
125
715
245
1632
1.63
9.82
3.0
2.6
2.28
2.32
g/l
0.40
231
1514
287
1992
1.58
9.69
3.2
2.9
2.45
2.44
mmol/l
0.33
253
1797
69
303
2.36
9.65
3.0
4.0
39.99
67.71
mg/l
0.72
59
256
69
303
2.36
9.65
3.0
4.0
78.51
39.98
mg/l
0.44
60
257
75
342
2.27
9.62
3.5
2.8
189.14
185.02
%
0.18
70
328
23
52
4.49
9.57
1.4
1.1
—
—
—
0
0
32
93
3.51
9.51
1.1
1.0
—
—
—
0
0
359
2630
1.52
9.47
3.2
2.8
337.44
341.88
umol/l
0.31
316
2339
164
993
1.76
9.37
3.0
2.5
0.22
0.21
g/l
0.65
151
930
44
157
2.87
9.35
1.3
1.5
—
—
—
0
0
227
1504
1.63
9.26
3.2
2.6
21.33
23.15
%
1.32
214
1414
1091
10106
1.91
9.25
31.4
17.9
139.12
139.64
mmol/l
8.75
1085
9919
79
376
2.18
9.15
1.9
1.9
—
—
—
0
0
25
63
4.03
9.08
1.4
1.1
—
—
—
0
0
41
144
2.91
8.97
1.7
1.6
—
—
—
0
0
586
4770
1.45
8.94
3.2
2.9
—
—
estimate
—
0
0
791
6815
1.48
8.94
3.4
3.2
—
—
—
0
0
347
2550
1.51
8.93
2.7
2.5
—
—
—
0
0
255
1753
1.58
8.89
3.1
2.6
12.26
13.25
umol/l
1.43
241
1635
1089
10122
1.86
8.54
31.6
18.1
3.96
3.97
mmol/l
0.69
1080
9919
80
394
2.10
8.51
1.4
1.4
—
—
—
0
0
50
202
2.54
8.40
1.4
1.5
—
—
—
0
0
381
2885
1.47
8.36
3.2
3.3
1176.42
1260.33
ng/l
0.24
327
2455
59
259
2.34
8.29
1.8
1.2
30.56
53.72
u/ml
—
7
23
123
715
1.80
8.05
4.8
4.3
5.24
5.12
kpa
0.89
117
696
110
618
1.86
8.04
4.6
4.3
1.87
1.60
mmol/l
0.35
84
462
47
189
2.55
7.98
2.1
2.0
4.78
4.86
mmol/24h
0.06
39
170
64
296
2.23
7.97
1.4
1.3
—
—
—
0
0
890
7933
1.48
7.78
5.2
4.3
14.80
14.72
pmol/l
0.35
847
7335
38
139
2.79
7.76
1.8
1.6
—
—
—
0
0
28
86
3.31
7.69
1.2
1.6
—
—
—
0
0
28
86
3.31
7.69
1.2
1.6
—
—
—
0
0
28
86
3.31
7.69
1.2
1.6
—
—
—
0
0
32
110
2.96
7.31
1.4
1.2
—
—
—
0
0
1015
9340
1.58
7.24
6.4
5.3
1.80
1.89
mu/l
1.82
962
8720
77
404
1.97
6.93
5.1
4.9
25.02
24.83
mmol/l
0.22
72
386
28
92
3.09
6.92
1.4
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
62
304
2.10
6.71
3.3
3.3
0.33
0.36
iu/ml
0.23
32
167
42
175
2.45
6.66
1.4
1.1
37198.14
69.23
iu/ml
—
7
34
21
59
3.61
6.61
1.3
2.0
29.38
29.24
umol/l
0.03
21
54
22
64
3.48
6.58
1.5
1.3
—
—
—
0
0
28
95
2.99
6.57
1.4
1.1
—
—
—
0
0
28
95
2.99
6.57
1.4
1.1
—
—
—
0
0
29
101
2.92
6.50
1.4
1.1
—
—
—
0
0
27
92
2.98
6.29
1.4
1.1
—
—
—
0
0
94
551
1.77
6.01
1.7
1.5
—
—
—
0
0
9
6
15.09
5.91
1.2
1.2
—
—
—
0
0
600
5125
1.34
5.88
3.7
3.1
148.64
116.36
ug/l
1.20
559
4821
104
640
1.68
5.60
3.1
3.5
4.46
4.58
pmol/l
0.50
89
572
26
94
2.81
5.49
3.0
5.1
41.36
46.32
u/ml
—
7
28
1022
9554
1.48
5.36
24.6
14.5
84.93
83.69
ml/min/173m2
0.91
964
8799
173
1214
1.50
5.34
3.0
3.2
7.66
7.89
umol/l
0.06
145
1071
146
988
1.54
5.34
4.3
3.3
—
—
—
0
0
23
82
2.84
5.00
1.1
1.1
0.09
1.57
nmol/l
—
5
14
112
727
1.60
4.91
2.4
3.2
176.05
205.28
ng/l
0.26
104
661
191
1390
1.45
4.89
1.7
1.9
1.58
1.47
%
1.16
164
1230
1111
10617
1.66
4.84
33.0
19.5
77.21
76.44
umol/l
0.30
1105
10510
52
272
1.95
4.79
3.9
3.2
2.04
2.23
index
0.12
28
156
368
2994
1.33
4.77
6.2
3.9
0.00
0.01
estimate
1.34
134
1078
118
785
1.56
4.66
1.3
1.2
160.84
151.35
u/ml
0.08
42
318
17
53
3.24
4.62
1.5
1.3
—
—
—
0
0
17
53
3.24
4.62
1.5
1.3
—
—
—
0
0
8
8
10.06
4.52
1.4
6.5
—
—
—
0
0
8
8
10.06
4.52
1.0
7.1
—
—
—
0
0
11
19
5.83
4.44
2.1
1.4
—
—
—
0
0
117
788
1.54
4.39
2.3
2.4
4.18
7.75
ug/l
3.77
97
698
29
125
2.35
4.36
1.9
1.6
20.79
26.12
ng/l
0.74
29
125
16
50
3.23
4.34
1.1
1.8
—
—
—
0
0
16
50
3.23
4.34
1.1
1.8
—
—
—
0
0
16
50
3.23
4.34
1.1
1.8
—
—
—
0
0
16
50
3.23
4.34
1.1
1.8
—
—
—
0
0
489
4184
1.29
4.27
6.0
3.7
0.02
0.03
estimate
0.40
119
967
1101
10539
1.57
4.26
18.6
11.8
27.45
26.60
u/l
0.79
1080
10284
17
57
3.01
4.13
13.9
8.7
5916.38
43.06
u/ml
—
8
17
55
311
1.81
4.04
1.4
1.3
—
—
—
0
0
11
22
5.04
4.01
1.1
1.4
—
—
—
0
0
14
36
3.92
4.00
3.3
3.3
35.13
34.35
umol/l
—
8
27
14
36
3.92
4.00
1.1
1.9
—
—
—
0
0
14
36
3.92
4.00
1.1
1.9
—
—
—
0
0
114
782
1.51
3.94
1.4
1.5
—
—
—
0
0
303
2456
1.31
3.93
6.1
3.9
1.02
1.63
kg/l
0.50
215
1644
17
59
2.91
3.91
1.4
1.4
15.76
23.51
umol/l
0.75
17
52
14
37
3.82
3.90
1.1
1.9
—
—
—
0
0
82
524
1.61
3.88
2.1
1.7
0.56
0.32
mg/l
1.30
29
250
21
85
2.50
3.64
1.5
2.6
821.52
1158.18
mg
0.47
21
85
11
25
4.43
3.62
3.5
2.4
15.35
17.24
umol/l
0.21
11
25
260
2085
1.32
3.62
1.6
1.7
29536309.82
38330920.93
pmol/l
0.11
237
1761
379
3196
1.27
3.58
5.3
4.2
10.38
9.35
mg/mmol
0.18
260
2019
34
171
2.02
3.56
1.2
1.1
—
—
—
0
0
51
295
1.76
3.51
2.0
2.0
6.15
4.66
iu/l
0.43
19
117
28
134
2.12
3.35
1.4
1.5
4148.36
361.43
pmol/l
0.47
23
119
246
1984
1.30
3.26
1.4
1.3
20.24
30.41
iu/ml
1.85
74
600
17
66
2.60
3.22
1.4
1.6
—
—
—
0
0
19
79
2.43
3.14
1.4
1.6
—
—
—
0
0
21
92
2.31
3.11
1.1
1.1
112.29
107.80
pmol/l
0.13
21
92
14
50
2.82
3.09
1.1
1.1
—
—
—
0
0
403
3473
1.24
3.07
5.0
3.5
7.53
7.79
mmol/l
0.50
348
2986
5
5
10.03
2.98
1.2
1.0
—
—
—
0
0
22
102
2.18
2.88
3.1
2.4
23.70
24.50
mg/l
—
10
43
13
47
2.79
2.82
2.5
2.3
43.44
80.54
ug/l
1.43
13
47
21
97
2.19
2.78
1.1
1.3
—
79.50
—
0
6
16
66
2.44
2.71
4.2
3.3
0.87
0.89
index
0.06
16
66
310
2629
1.24
2.69
1.4
1.3
0.99
1.41
u/ml
0.70
62
739
49
304
1.64
2.68
1.2
1.2
—
—
—
0
0
49
305
1.63
2.65
1.2
1.2
—
—
—
0
0
15
61
2.48
2.62
1.6
1.8
—
—
—
0
0
15
61
2.48
2.62
1.6
1.8
—
—
—
0
0
20
93
2.17
2.62
2.5
2.9
—
—
—
0
0
62
913
0.66
2.61
1.5
1.7
3.38
3.49
mmol/l
0.38
44
655
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
12
44
2.74
2.55
1.3
2.3
2.48
1.95
umol/l
1.53
12
39
30
165
1.84
2.50
1.2
1.3
—
—
—
0
0
5
8
6.27
2.37
10.0
15.6
0.22
0.28
umol/l
—
5
8
13
52
2.52
2.36
1.9
4.6
69.85
66.27
mg/l
0.11
13
37
59
396
1.52
2.35
1.8
1.7
—
—
—
0
0
105
786
1.37
2.34
5.6
3.7
1.21
1.23
mmol/l
2.36
94
683
24
126
1.92
2.32
1.1
1.3
0.19
0.32
nmol/l
0.39
19
96
21
105
2.02
2.31
1.8
2.3
16.22
20.72
nmol/l
2.28
21
98
14
60
2.35
2.22
1.4
1.6
—
—
—
0
0
67
470
1.45
2.17
2.1
2.4
3639.05
5084.09
u/l
0.24
22
202
8
26
3.09
2.01
2.5
3.8
10.34
10.15
kpa
—
8
26
8
26
3.09
2.01
2.5
3.8
4.46
5.02
kpa
—
8
26
20
104
1.94
2.01
4.9
3.8
—
—
—
0
0
59
411
1.46
2.00
1.3
1.3
245.28
253.85
miu/ml
0.05
21
196
13
57
2.29
1.98
1.5
1.6
—
—
—
0
0
104
800
1.33
1.97
2.9
2.6
76.02
68.54
ml/min/173m2
0.24
45
339
10
39
2.58
1.94
1.4
1.4
—
—
—
0
0
10
39
2.58
1.94
1.4
1.4
—
—
—
0
0
6
16
3.76
1.93
1.2
1.0
—
—
—
0
0
14
65
2.17
1.88
1.6
1.8
—
—
—
0
0
5
12
4.18
1.82
3.2
2.2
—
—
—
0
0
5
12
4.18
1.82
1.2
1.7
—
—
—
0
0
11
48
2.30
1.70
2.9
2.3
—
—
—
0
0
38
251
1.53
1.70
2.7
2.0
126.40
130.08
g/l
0.38
25
200
346
3085
1.17
1.69
5.2
3.3
0.00
0.04
estimate
0.77
120
934
176
1476
1.23
1.69
2.3
2.2
—
—
—
0
0
22
126
1.76
1.68
1.4
1.4
—
—
—
0
0
11
49
2.26
1.64
2.5
3.8
88.17
143.72
umol/l
—
6
32
961
9264
1.19
1.62
7.2
6.1
39.89
38.94
mmol/mol
1.94
909
8739
131
1069
1.25
1.62
9.4
6.8
—
—
—
0
0
5
14
3.58
1.61
3.2
2.1
—
—
—
0
0
98
1231
0.78
1.61
1.7
1.9
3.58
3.51
ratio
0.17
76
959
10
44
2.28
1.55
1.1
1.3
97.00
116.60
nmol/l
—
5
31
162
1360
1.22
1.55
2.1
2.1
—
—
—
0
0
5
15
3.34
1.52
1.2
1.0
179.20
64.00
titre
—
5
15
21
124
1.71
1.47
1.4
1.4
—
—
—
0
0
20
117
1.72
1.45
1.4
1.5
—
—
—
0
0
20
117
1.72
1.45
1.4
1.5
—
—
—
0
0
44
311
1.43
1.45
1.8
1.5
274.50
289.58
ug/g
0.14
27
185
13
66
1.98
1.43
1.0
1.2
7.38
12.28
u/l
—
8
60
9
39
2.32
1.43
2.8
2.8
0.61
0.61
mmol/l
—
9
39
172
1466
1.20
1.42
2.6
2.6
185.50
122.84
ug/g
0.75
141
1187
20
118
1.71
1.42
1.4
1.5
—
—
—
0
0
21
126
1.68
1.40
1.4
1.4
—
—
—
0
0
113
924
1.25
1.40
2.3
2.4
12.93
13.12
nmol/l
0.08
102
848
15
262
0.57
1.39
1.5
1.6
—
—
—
0
0
209
1820
1.18
1.36
1.3
1.3
9.33
11.89
u/ml
0.32
73
717
17
98
1.75
1.31
1.9
1.6
—
—
—
0
0
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
30
434
0.68
1.26
1.2
1.8
3.66
4.03
mg/l
0.11
21
321
1118
10987
1.27
1.26
40.1
23.4
7.10
6.75
e9/l
5.30
1102
10763
1117
10978
1.27
1.24
40.2
23.4
256.16
251.54
e9/l
1.43
1105
10783
15
85
1.77
1.23
1.9
1.9
—
—
—
0
0
1117
10980
1.27
1.22
40.0
23.3
91.06
90.74
fl
1.35
1110
10883
1117
10983
1.26
1.19
40.1
23.4
4.40
4.52
e12/l
12.39
1099
10765
1117
10983
1.26
1.19
41.3
23.9
39.70
40.50
%
7.77
1109
10877
16
94
1.71
1.17
1.2
1.2
1.07
4.74
u/ml
—
9
51
8
39
2.06
1.15
1.4
1.2
116.38
104.97
%
—
8
33
8
39
2.06
1.15
1.3
1.3
—
—
—
0
0
1117
10988
1.25
1.15
40.5
23.5
132.18
135.81
g/l
13.62
1109
10888
10
51
1.97
1.11
4.0
2.8
0.95
1.47
%
—
10
51
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
243
2181
1.14
1.08
1.7
1.6
—
—
—
0
0
28
194
1.45
1.07
1.2
1.2
140.92
34.28
u/l
0.65
21
171
40
297
1.36
1.05
1.7
1.9
174.26
216.75
pmol/l
1.60
35
281
9
46
1.96
1.03
1.2
1.2
416.22
462.68
u/l
—
9
40
7
35
2.01
1.00
2.6
1.7
—
—
—
0
0
69
559
1.25
0.98
1.2
1.4
—
—
—
0
0
27
190
1.43
0.97
1.6
1.7
—
—
—
0
0
7
36
1.95
0.97
2.4
4.6
—
—
—
0
0
101
857
1.20
0.93
2.2
2.1
—
—
—
0
0
22
152
1.46
0.88
1.4
1.5
—
—
—
0
0
317
2931
1.11
0.87
4.1
5.2
2.31
2.58
ug/l
0.26
292
2648
25
178
1.41
0.86
4.3
3.3
0.84
0.85
nmol/l
0.03
18
146
132
1158
1.16
0.83
4.3
4.6
31.44
31.85
%
0.14
95
778
85
719
1.20
0.83
2.2
2.0
—
—
—
0
0
30
223
1.35
0.82
2.3
2.5
98.49
112.62
ug/min
0.12
19
138
46
575
0.79
0.81
1.6
1.6
791.97
975.56
mu/l
1.15
36
482
16
106
1.52
0.79
1.1
1.3
—
—
titre
—
0
0
35
269
1.31
0.78
1.5
1.4
—
—
—
0
0
13
198
0.65
0.77
1.8
1.6
51.09
54.86
ug/l
0.21
13
198
19
133
1.44
0.74
1.1
1.3
—
—
—
0
0
45
364
1.25
0.70
1.6
1.5
10.16
9.26
u/l
0.17
35
292
960
9781
0.91
0.68
5.1
4.8
1.42
1.45
mmol/l
1.31
893
9129
16
226
0.70
0.67
2.0
1.8
—
—
—
0
0
31
389
0.79
0.60
1.7
1.4
—
—
—
0
0
8
52
1.54
0.59
1.6
1.1
125.71
226.34
iu/ml
—
8
52
30
237
1.27
0.58
1.1
1.2
—
—
—
0
0
8
53
1.51
0.58
2.8
1.8
155.37
107.01
ng/l
—
8
53
13
89
1.47
0.58
1.5
2.1
—
—
—
0
0
17
124
1.38
0.56
2.1
2.6
1.20
1.19
mmol/l
0.05
17
124
6
37
1.62
0.55
2.3
1.4
—
—
—
0
0
13
90
1.45
0.55
1.3
1.4
15942.88
114776.24
e6/l
—
8
45
41
341
1.21
0.53
1.5
1.5
—
—
—
0
0
9
65
1.39
0.50
1.6
1.6
—
—
—
0
0
968
9825
0.92
0.50
5.2
4.9
4.56
4.65
mmol/l
2.20
904
9224
17
127
1.34
0.49
2.1
2.6
4.18
4.06
mmol/l
0.60
17
127
17
127
1.34
0.49
2.1
2.6
104.35
105.04
mmol/l
0.13
17
127
107
966
1.12
0.49
3.6
4.4
6.83
23.79
ug/l
1.17
85
793
21
265
0.79
0.46
1.1
1.2
1.70
2.92
u/ml
0.40
15
146
5
83
0.60
0.45
1.0
1.4
—
—
—
0
0
36
302
1.20
0.44
1.1
1.1
1.68
6.12
eliau/ml
—
5
38
67
594
1.14
0.43
1.1
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
1.46
—
0
11
985
9950
0.94
0.31
5.9
5.5
2.62
2.74
mmol/l
3.92
915
9310
30
258
1.17
0.31
1.9
1.6
10845.83
12769.96
e6/l
0.16
23
186
184
1748
1.06
0.30
2.9
3.1
0.75
0.76
ug/l
0.04
128
1062
63
573
1.11
0.29
1.4
1.4
27.58
24.56
iu/l
0.28
51
481
960
9508
1.05
0.26
5.4
4.8
6.02
5.90
mmol/l
1.46
891
8790
30
338
0.88
0.23
1.5
1.4
—
—
—
0
0
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
9.10
—
0
5
0
11
0.00
0.21
0.0
2.5
—
0.55
—
0
11
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
0.26
—
0
10
0
12
0.00
0.21
0.0
1.0
—
3.12
—
0
5
0
13
0.00
0.21
0.0
1.0
—
0.05
—
0
6
0
14
0.00
0.20
0.0
1.0
—
0.00
—
0
7
20
174
1.15
0.19
1.1
1.1
3.54
2.03
eliau/ml
—
7
78
18
156
1.16
0.18
1.3
1.3
—
—
—
0
0
171
1651
1.04
0.17
1.6
1.5
—
—
—
0
0
7
61
1.15
0.17
1.1
1.2
10.14
8.23
mm/h
—
7
61
13
152
0.85
0.17
1.2
1.2
—
—
—
0
0
5
70
0.71
0.16
1.2
1.4
131.44
175.71
pmol/l
—
5
70
410
4174
0.97
0.16
2.0
1.9
1.41
1.37
mmol/l
0.52
360
3591
6
77
0.78
0.15
1.0
1.5
84.67
78.73
umol/l
—
6
77
43
400
1.08
0.15
1.8
1.9
—
—
—
0
0
38
406
0.93
0.12
1.2
1.1
0.62
0.64
ratio
—
7
47
10
85
1.18
0.12
1.4
1.2
—
—
—
0
0
10
85
1.18
0.12
1.4
1.2
—
—
—
0
0
42
446
0.94
0.12
1.3
1.2
0.93
0.91
g/l
0.21
42
446
30
322
0.93
0.11
1.4
1.5
1.20
1.16
ratio
0.08
16
203
30
322
0.93
0.11
1.4
1.5
0.89
1.18
ratio
2.00
18
203
30
322
0.93
0.11
1.4
1.5
1.05
0.97
ratio
0.56
16
203
41
432
0.95
0.09
1.2
1.1
1.50
1.53
g/l
0.32
41
432
32
339
0.94
0.09
1.5
1.5
46.56
60.74
ug/l
1.16
24
287
30
317
0.94
0.07
1.4
1.4
—
—
—
0
0
7
84
0.83
0.07
1.1
1.2
—
—
—
0
0
237
2340
1.02
0.06
3.6
4.3
21.32
21.32
%
0.00
103
1052
13
142
0.91
0.06
1.0
1.0
—
—
—
0
0
14
129
1.09
0.05
2.6
2.7
33.29
32.85
pg
0.16
14
129
930
9326
0.99
0.05
4.5
4.2
1.37
1.29
mmol/l
2.18
862
8639
11
100
1.10
0.05
1.2
1.4
6.38
6.47
mmol/l
0.05
11
95
17
164
1.04
0.00
1.8
2.8
6.83
7.00
umol/l
—
9
127
41
404
1.02
0.00
1.8
1.7
9.31
8.34
u/ml
—
8
98
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
6.17
—
0
7
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
65
0.92
-0.00
1.2
1.5
—
391.43
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.0
2.2
—
1128.16
—
0
14
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
1.51
—
0
8
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ENCEPHALITIS – Encephalitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).